Trials / Terminated
TerminatedNCT04883840
Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 177 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
* Evaluation of the microbiota modulation away from inflammation associated microbiota profile Bacteroides2 (Bact2) * Evaluation of the effect of microbiota modulation on disease activity in ulcerative colitis and Crohn's disease patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin 10mg | Daily dose of one medication over 8 week period then switch to another medication over an 8 week period (type of medication during each intervention period is blinded and then randomized). |
Timeline
- Start date
- 2020-10-22
- Primary completion
- 2025-10-11
- Completion
- 2025-10-11
- First posted
- 2021-05-12
- Last updated
- 2025-11-25
Locations
3 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04883840. Inclusion in this directory is not an endorsement.